Folsom Metal Products recalled 160 units of distraction pins due to unvalidated shelf life labeling. The recall affects devices distributed across multiple states, including California and Texas. Patients and healthcare providers should stop using the product immediately.
Labeling includes shelf life that has not been validated.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Folsom Metal Products, Inc. or your healthcare provider for instructions. Notification method: Letter
The recall involves Frontier Devices, REF: 301.912S2, 12 mm Distraction Pin, sold in ten double packs. These devices were distributed nationwide from August 1, 2020, to July 30, 2025.
The recall stems from labeling that includes a shelf life that has not been validated. This lack of validation poses potential health risks to users.
No specific incidents or injuries linked to this recall have been reported at this time. The potential risks arise from the unvalidated shelf life.
Patients and healthcare providers should stop using the distraction pins immediately. Contact Folsom Metal Products, Inc. or your healthcare provider for instructions on the recall.
For more information, reach Folsom Metal Products, Inc. via their official website or through the FDA recall notification letter.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.